InnovAge Holding Corp

InnovAge Holding Corp (INNV) Stock Analysis

$9.550

+0.031 (+0.32%)At close

Loading chart…
High
9.700
Open
9.530
VWAP
9.55
Volume
460.86K
Mkt Cap
712.58M
Low
9.396
Amount
4.40M
EV/EBITDA, TTM
16.23

InnovAge Holding Corp. is a healthcare delivery platform. The Company is engaged in managing the care of high-cost, frail, and dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE). Its programs are designed to allow frail seniors to live life on their terms by aging in place, in their own homes and communities, for as long as safely possible. Through its PACE program, it offers a range of medical and ancillary services for seniors, including in-home care services (skilled, unskilled and personal care), center services such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to and from the PACE center, and third-party medical appointments and care management. Its participant-centered approach is led by the Company's Interdisciplinary Care Teams (IDTs), who oversee all aspects of each participant’s care plan.

AI analysis of InnovAge Holding Corp (INNV)

Buy

InnovAge Holding Corp is a good buy right now, with a current price of $9.55 and an analyst price target of $14, indicating a potential upside of 46.5%. The stock has shown strong momentum with a year-to-date change of +84.01% and a 5-day change of +7.91%. However, the RSI is at 76.43, suggesting it may be overbought, which is a risk to consider.

Valuation Metrics

The current forward P/E ratio for InnovAge Holding Corp (INNV) is 13.66, compared to its 5-year average forward P/E of -108.30.

Forward P/E

Fair
5Y Average P/E
-108.30
Current P/E
13.66
Overvalued
968.83
Undervalued
-1185.43

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
-7.89
Current EV/EBITDA
16.23
Overvalued
181.44
Undervalued
-197.21

Forward P/S

Fair
5Y Average P/S
0.98
Current P/S
1.12
Overvalued
1.27
Undervalued
0.69

Alphio AI Price Scenarios for INNV

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%INNV

$4.78

Scenario price

B

Base

Base · 50%INNV

$4.75

Scenario price

B

Bear

Bear · 25%INNV

$3.97

Scenario price

Whales holding INNV

C

Coliseum Capital Management, LLC

+ HoldingINNV

-27.95%

3M Return

Events Timeline

2026-09-23 (ET)

16:30:00

Major Averages Close Lower as 10-Year Treasury Yield Hits 5.13%

12:00:00

Major Averages Broadly Lower as Oil Rises Over 1%

2026-09-22 (ET)

22:00:00

Barclays, Goldman Sachs, and Wells Fargo Jointly Manage Offering Priced at $9.25

20:00:00

Dow Falls, Nasdaq Hits New Record Highs

17:00:00

Barclays, Goldman Sachs, and Wells Fargo Jointly Manage Offering

News

INNV FAQ — answered by Alphio AI

InnovAge Holding Corp. is a healthcare delivery platform. The Company is engaged in managing the care of high-cost, frail, and dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE). Its programs are designed to allow frail seniors to live life on their terms by aging in place, in their own homes and communities, for as long as safely possible. Through its PACE program, it offers a range of medical and ancillary services for seniors, including in-home care services (skilled, unskilled and personal care), center services such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to and from the PACE center, and third-party medical appointments and care management. Its participant-centered approach is led by the Company's Interdisciplinary Care Teams (IDTs), who oversee all aspects of each participant’s care plan. It operates in the Healthcare sector (SERVICES-HEALTH SERVICES industry).

InnovAge Holding Corp is a good buy right now, with a current price of $9.55 and an analyst price target of $14, indicating a potential upside of 46.5%. The stock has shown strong momentum with a year-to-date change of +84.01% and a 5-day change of +7.91%. However, the RSI is at 76.43, suggesting it may be overbought, which is a risk to consider.

Community

More ↗

No posts yet

Sign up or log in to join the discussion

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading